GlaxoSmithKline ( ($GB:GSK) ) has provided an announcement. GSK has announced the purchase of 170,000 of its own ordinary shares as part of its ...

AnaptysBio ( ($ANAB) ) has provided an update. On November 20, 2025, AnaptysBio filed a complaint in Delaware Chancery Court against TESARO, Inc.

It has been about a month since the last earnings report for GSK (GSK). Shares have added about 10.3% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up ...

Deutsche Numis analyst Emmanuel Papadakis reiterated a Buy rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of p1,950.00. The company’s shares opened today at p1,537.00.

In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Buy rating on GlaxoSmithKline (GSK – Research Report), with a price target of £18.50. The company’s shares opened today ...

India's GlaxoSmithKline Pharmaceuticals reported slightly higher second-quarter profit on Thursday, led by steady demand for its specialty medicine portfolio.

That next blockbuster drug? It all begins with a hypothesis: GlaxoSmithKline just announced the winners of its second Discovery Fast Track Challenge – a competition that teams up American and European ...

GSK (GSK) came out with quarterly earnings of $1.13 per share, beating the Zacks Consensus Estimate of $1.08 per share. This compares to earnings of $1.09 per share a year ago. These figures are ...

Arab Finance: GlaxoSmithKline (GSK – Egypt) posted a 71.46% year-on-year (YoY) consolidated profit hike during the first nine months of 2025, according to the financial statements filed to the ...

GlaxoSmithKline (GSK) will partner with Hengrui Pharma to develop up to 12 treatments for indications in respiratory, immunology, and inflammation (RI&I) as well as oncology, through a collaboration ...

As China's healthcare and policy environment continues to improve, global pharmaceutical company GlaxoSmithKline (GSK) is using the China International Import Expo (CIIE) to advance innovation in ...